PHAT FY 2021 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$521,000

Operating Income

-$135M

Net Income

-$144M

EPS (Diluted)

$-4.00

Cash Flow

Operating Cash Flow

-$148M

Free Cash Flow

-$149M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$189M

Total Liabilities

$117M

Stockholders' Equity

$72M

Cash & Equivalents

$183M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$521,000	-$300,000	-73.7%
Operating Income	-$135M	-$126M	-7.5%
Net Income	-$144M	-$129M	-11.5%